In contrast, Mint3 activates the transcriptional activity of HIF-1α in specific types of cells, such as cancer cells and macrophages, by suppressing FIH-1, and Mint3 KO mice showed no apparent abnormality23,24, which promises less adverse effects with Mint3 inhibitors. Here, HIF1A is linked to cancer.